4 June 2015
www.intgold.com.au
Company Announcements Office Australian Securities Exchange Level 6, 20 Bridge Street
SYDNEY NSW 2000
Via E Lodgement
WINTER GARDEN SIGNS RESEARCH AGREEMENT WITH NATIONAL UNIVERSITY OF URUGUAY
International Goldfields Limited ("IGS") (ASX:IGS) is pleased to advise that Winter Garden Bioscience ("Winter Garden" or "WG") has signed an exclusive, multi-year, renewable research agreement with the Science Faculty of the National University of Uruguay (Universidad de la Republica) to further research methodology associated with the development of the WG plant registration program. This research will involve genetic marker identification and synthetic seed propagation for Cannabis sativa sp.
WG is an emerging agriculture bioscience and biotechnology company in which IGS
has agreed to acquire an 85% interest (refer ASX announcement dated 1 May 2015).
Dr. Sabina Vidal, project manager for the Faculty of Science said: "Genetic markers are essential for the unequivocal identification of any given cultivar and its genetic relations to other cultivars which in turn is an integral part of plant registration."
The agreement concluded between WG and the UdlaR includes access to and collaboration with a private research institute (PCTP) where characterisation and product development work will be carried out. Coordinator of the project for the PCTP, Caterina Rufo, a Ph.D. in Food and Nutritional Science alongside Helena Pardo, a Ph.D. in Chemistry, will act as liaison between the PCTP and the technical management staff of WG.
The agreement blankets all facets of Cannabis and hemp, exclusively and at cost. Additionally it affords WG access to a team of PhD students, world renowned researchers and cutting edge equipment.
Winter Garden is currently the only company with the ability to research and internationally register varieties of Cannabis sativa sp. on a commercial level.
Relationships with governmental institutions such as the Universidad de la Republica are of great value to the research conducted at the company's laboratories and give the company the ability to move quickly towards the registration of new varieties.
Winter Garden Bioscience director Julian Strauss: "All our research and laboratory partners are strategically chosen to give us the ability to advance Winter Garden Bioscience's projects rapidly and create an environment that allows us to bring new
Michael Edwards
Chairman
David Tasker
Director
Travis Schwertfeger
Director
COMPANY SECRETARYJane Flegg
REGISTERED OFFICE AND PRINCIPLE PLACE OF BUSINESSGround Floor, 1 Havelock Street
WEST PERTH WA 6005
PO Box 684
WEST PERTH WA 6872
COMMUNICATION DETAILSTelephone: +61 8 9488 5220
Facsimile: +61 8 9324 2400
Web Address: www.intgold.com.au Email Address: info@intgold.com.au
AUSTRALIAN BUSINESS NUMBER69 099 544 680
SHARE REGISTRYAdvanced Share
Registry Services Pty Ltd
150 Stirling Hwy
Nedlands WA 6009
MEDIA CONTACTTony Dawe
PPR
T: 08 9388 0944
E: tony.dawe@ppr.com.au
ASX CODEIGS
www.intgold.com.au
registered varieties to our international partners, within a very short timeframe."
"With the existing relationships and the work done to date we anticipate registering our first varieties within next
10 months, which will create significant revenue opportunities for WG."
For and on behalf of the board
David Tasker
Director
International Goldfields Professional Public Relations
T: +61 8 9488 5220 Tony Dawe
T: +61 8 9388 0944
M: +61 405 989 743
E: info@intgold.com.au E: tony.dawe@ppr.com.au
Winter Garden Bioscience is an advanced developer of mass market non-synthetic cannabis products, and is focused on the production of cannabis extracts, derivatives, delivery systems and related intellectual property for sale into the rapidly growing international marketplace for therapeutic medicinal cannabis products.
Winter Garden Bioscience is fully licensed to export cannabinoid products, including its high-potency CBD extracts. The Company plans to primarily target wholesale distribution partners which have developed CBD based product lines in the United States, Canada and Europe. This includes pharmaceutical and nutraceutical companies, in addition to companies focused on the marijuana marketplace. Winter Garden will also look at making its products available to retail consumers in North America and Europe which will supplement its wholesale revenues.
www.intgold.com.au
distributed by |